PDI Appoints Antonio Sanchez-Cordero, Senior Vice President, Corporate Strategy, Business Development, and Licensing

Reinforcing Its Commitment to Leadership In Infection Provention

PDI Healthcare Simplifies Ease and Speed of SSI and HAI Protection with New Profend™ Nasal Decolonization Kit

Fast-acting, effective 10 percent PVP-iodine Nasal swabstick designed to maximize patient comfort, ease application process in support of antibiotic stewardship

PDI Strengthens Team with New Senior Leadership Appointments

Infection prevention leader welcomes Tom McCurdy as Senior Vice President and General Manager, PDI Healthcare and promotes Esperanza Carrion to Vice President and General Manager, Sani Professional®

PDI Appoints New President & Chief Operating Officer, Kent J. Davies

ORANGEBURG, NY – October 4, 2017 – PDI, a leader in infection prevention products and solutions, announces the appointment of Kent J. Davies as President and Chief Operating Officer.   Through this new position and appointment, PDI will continue to accelerate its evolution as an infection prevention solutions leader.  In this role, Kent will be responsible for driving PDI’s enterprise-wide commercial strategy and have overall responsibility for its operational and financial performance.

PDI Healthcare Hosts Educational Session at AVA 2017 on CHG’s Role in CLABSI Prevention

PDI’s Prevantics® Device Swab Highlighted in Poster Presentation

PDI Healthcare Introduces Newest Product at APIC 2017, Featuring Proprietary ACCELOQUAT™ Technology

PDI Hosts Educational Session, Celebrates 10th Annual ‘Extravaganza’ with Local Food Truck Fare

 

PDI Welcomes Industry-Leading Experts to Further the Advancement of its leading Infection Prevention Technology

Dr. Rutala and Dr. Weber join as exclusive consultants to help shape disinfection, antisepsis and hand hygiene efforts

New Randomized Study Shows 3.15% Chlorhexidine Gluconate/70% Isopropyl Alcohol Solution Most Effective for Disinfecting Needleless Access Sites

New Randomized Study Shows 3.15% Chlorhexidine Gluconate/70% Isopropyl Alcohol Solution Most Effective for Disinfecting Needleless Access Sites at 5 Second Scrub Time

PDI Prevantics® Device Swab is the only 3.15% Chlorhexidine Gluconate/70% alcohol solution to receive 510k clearance by the FDA

PDI and SABIC Join Forces to Test Medical Device Plastics and to Help Improve Patient Protection from Infection

Leaders in infection prevention and thermoplastic technology conduct stress-cracking study to unravel compatibility issues

 

PDI Bolsters Momentum with New Leadership Appointments and Growth Plans

Infection prevention leader welcomes new Vice President, Marketing Elise Tordella and promotes Chris Puricelli to Vice President, Strategy